Literature DB >> 25486226

Clinical chemistry and dried blood spots: increasing laboratory utilization by improved understanding of quantitative challenges.

Donald H Chace1, Víctor R De Jesús, Alan R Spitzer.   

Abstract

Entities:  

Keywords:  biomarkers; clinical chemistry; dried blood spots; isotope dilution mass spectrometry; metabolism; newborn screening

Mesh:

Substances:

Year:  2014        PMID: 25486226      PMCID: PMC4528187          DOI: 10.4155/bio.14.237

Source DB:  PubMed          Journal:  Bioanalysis        ISSN: 1757-6180            Impact factor:   2.681


× No keyword cloud information.
  21 in total

Review 1.  Use of tandem mass spectrometry for multianalyte screening of dried blood specimens from newborns.

Authors:  Donald H Chace; Theodore A Kalas; Edwin W Naylor
Journal:  Clin Chem       Date:  2003-11       Impact factor: 8.327

2.  A glowing future for dried blood spot sampling.

Authors:  Neil Spooner
Journal:  Bioanalysis       Date:  2010-08       Impact factor: 2.681

3.  Improving and assuring newborn screening laboratory quality worldwide: 30-year experience at the Centers for Disease Control and Prevention.

Authors:  Víctor R De Jesús; Joanne V Mei; Carol J Bell; W Harry Hannon
Journal:  Semin Perinatol       Date:  2010-04       Impact factor: 3.300

4.  Electrospray tandem mass spectrometry for analysis of acylcarnitines in dried postmortem blood specimens collected at autopsy from infants with unexplained cause of death.

Authors:  D H Chace; J C DiPerna; B L Mitchell; B Sgroi; L F Hofman; E W Naylor
Journal:  Clin Chem       Date:  2001       Impact factor: 8.327

5.  Comparison of multiple steroid concentrations in serum and dried blood spots throughout the day of patients with congenital adrenal hyperplasia.

Authors:  Kyriakie Sarafoglou; John H Himes; Jean M Lacey; Brian C Netzel; Ravinder J Singh; Dietrich Matern
Journal:  Horm Res Paediatr       Date:  2010-08-25       Impact factor: 2.852

6.  Comparison of amino acids and acylcarnitines assay methods used in newborn screening assays by tandem mass spectrometry.

Authors:  Víctor R De Jesús; Donald H Chace; Timothy H Lim; Joanne V Mei; W Harry Hannon
Journal:  Clin Chim Acta       Date:  2010-02-01       Impact factor: 3.786

7.  Medium-chain acyl-CoA dehydrogenase (MCAD) deficiency: diagnosis by acylcarnitine analysis in blood.

Authors:  J L Van Hove; W Zhang; S G Kahler; C R Roe; Y T Chen; N Terada; D H Chace; A K Iafolla; J H Ding; D S Millington
Journal:  Am J Hum Genet       Date:  1993-05       Impact factor: 11.025

8.  Use of phenylalanine-to-tyrosine ratio determined by tandem mass spectrometry to improve newborn screening for phenylketonuria of early discharge specimens collected in the first 24 hours.

Authors:  D H Chace; J E Sherwin; S L Hillman; F Lorey; G C Cunningham
Journal:  Clin Chem       Date:  1998-12       Impact factor: 8.327

9.  Application of dried blood spots combined with HPLC-MS/MS for the quantification of acetaminophen in toxicokinetic studies.

Authors:  Matt Barfield; Neil Spooner; Rakesh Lad; Simon Parry; Susan Fowles
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2008-05-22       Impact factor: 3.205

10.  Analysis of perchlorate in dried blood spots using ion chromatography and tandem mass spectrometry.

Authors:  Samaret M Otero-Santos; Amy D Delinsky; Liza Valentin-Blasini; Jarad Schiffer; Benjamin C Blount
Journal:  Anal Chem       Date:  2009-03-01       Impact factor: 6.986

View more
  3 in total

1.  Response to Gelb et al.: "Comparison of tandem mass spectrometry to fluorimetry for newborn screening of LSDs".

Authors:  David S Millington
Journal:  Mol Genet Metab Rep       Date:  2017-07-06

2.  Misinformation regarding tandem mass spectrometric vs fluorometric assays to screen newborns for LSDs.

Authors:  David S Millington; Deeksha M Bali
Journal:  Mol Genet Metab Rep       Date:  2017-05-10

3.  Combining lipidomics and machine learning to measure clinical lipids in dried blood spots.

Authors:  Stuart G Snowden; Aniko Korosi; Susanne R de Rooij; Albert Koulman
Journal:  Metabolomics       Date:  2020-07-24       Impact factor: 4.290

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.